Omnicell Inc
SWB:OC9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Omnicell Inc
SWB:OC9
|
US |
|
S
|
Shaftesbury Capital PLC
F:C20
|
UK |
|
V
|
Verbrec Ltd
F:47L
|
AU |
|
S
|
Shaftesbury Capital PLC
OTC:CCPPF
|
UK |
|
U
|
UniCredit SpA
OTC:UNCRY
|
IT |
|
Bleecker SA
PAR:BLEE
|
FR |
|
C
|
Castec Korea Co Ltd
KOSDAQ:071850
|
KR |
|
ANTA Sports Products Ltd
F:AS7
|
CN |
|
Sunil Healthcare Ltd
BSE:537253
|
IN |
|
ABM Investama Tbk PT
F:0A1
|
ID |
|
V
|
Volatus Aerospace Inc
XMUN:ABB
|
CA |
|
R
|
Roots Corp
F:4RO
|
CA |
|
P
|
Precious Shipping PCL
SET:PSL
|
TH |
|
C
|
Citigroup Inc
XMUN:TRVC
|
US |
|
M
|
Microsoft Corp
XMUN:MSF
|
US |
Intrinsic Value
Is OC9 undervalued or overvalued?
See the intrinsic value estimate for 
Omnicell Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Omnicell Does
Omnicell makes automation and software for hospitals, pharmacies, and health systems that need to store, track, dispense, and replenish medicines and other supplies. Its products include medication cabinets, robotics, packaging systems, and software that help nurses and pharmacists manage drugs more safely and with fewer manual steps. The company sits in the middle of the pharmacy supply chain, where accuracy and inventory control matter a lot.
- Headquarters
- United States of America US
- Employees
- 3 580
- IPO date
- Aug 8, 2001
Omnicell has no economic moat
Omnicell Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Omnicell Inc
Earnings Waterfall
Omnicell Inc
The intrinsic value for Omnicell Inc (OC9) under the Base Case is hidden EUR.
Compared with the current market price of 32 EUR, the stock appears hidden.
